NCT05529342Enrolling by invitation
Long-term Follow-up of Study Participant Treated With Lentiviral-Based Genetically Modified Autologous Cell Product ,AGT103-T
A Long-Term Follow-Up Study of Participants Treated With the Lentiviral-Based Genetically Modified, Autologous Cell Product, AGT103-T
Source: ClinicalTrials.gov · Last updated 2 Dec 2022 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Long-term follow-up of study subjects who received AGT103-T product in HIV study. The AGT103-T is genetically modified cells that resist infection with HIV causing a depletion of HIV in HIV-infected study participants.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 7 (estimated)
- First submitted
- 2 Sept 2022
- Start date
- Aug 2022
- Primary completion date
- May 2038
- Lead sponsor
- American Gene Technologies International Inc.
- Diseases
- HIV
- NCT number
- NCT05529342
What you commit to
- Study type: Observational
- Planned participants: 7
- From Aug 2022 to the primary completion date, May 2038
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- 1\. Did not receive the investigational product, AGT103-T
Who the study is looking for
- Received the investigational product, AGT103-T, in the AGT-sponsored AGT-HC168 clinical trial
- Provided written informed consent, signed and dated by the study participant in the long-term follow-up study
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Washington Health Institute Coordinator of this site? Confirm its status | Washington D.C. | United States | Unknown status |
| Georgetown University Coordinator of this site? Confirm its status | Washington D.C. | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.